Equities

Shilpa Medicare Ltd

SHILPAMED:NSI

Shilpa Medicare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)460.55
  • Today's Change6.55 / 1.44%
  • Shares traded517.48k
  • 1 Year change+99.80%
  • Beta0.9286
Data delayed at least 15 minutes, as of Mar 28 2024 10:23 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • SHILPAMED:NSI price reached a new 52-week high of 466.20 at 09:50 BST
  • SHILPAMED:NSI price moved over +1.04% to 454.90

Key statistics

Shilpa Medicare Ltd (SHILPAMED:NSI) set a new 52-week high during today's trading session when it reached 469.00. Over this period, the share price is up 101.07%.
52-week range
Today
222.60Mar 28 2023469.00Mar 28 2024
Open454.00
High469.00
Low454.00
Bid--
Offer460.55
Previous close454.00
Average volume564.64k
Shares outstanding86.80m
Free float27.42m
P/E (TTM)--
Market cap39.41bn INR
EPS (TTM)-0.0714
INR
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateSep 19 2022
Div pay-dateOct 28 2022
Data delayed at least 15 minutes, as of Mar 28 2024 10:23 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.